This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
His candid insights cover everything from managing non-payment issues to adapting to generational shifts among doctors, providing listeners with actionable strategies for success in the medical sales field.
So should pharma be in the app business? The average cost to make an app ranges from $80K – $250K+, depending on what type of app you want to create: Simple apps cost up to $80,000. ” An app can help patients manage their chronic conditions but there are a lot of variables. Medication management. This is new to pharma.
Introduction In the highly regulated world of pharmaceutical marketing , mastering Google Ads management can be a game-changer. With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions.
You need to work with pharma clients to educate them on the complicated path from awareness to requesting an Rx. 2wo: The pharma product website is a living entity. Agencies should persuade clients to use their DTC budgets to reach their target market better, whether in the doctor’s office or online.
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharma reps. The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharma reps to provide that information. doctors and 45% of all NPS and physician assistants as verified members.
Nowhere is this more evident than in pharma TV ads like Tepezza. This could especially be true for pharma TV ads which seem to run back to back to back. When it comes to pharma DTC increased frequency is NOT going. 3hree: They believe people see a TV ad for a pharma product and ask their doctor for it.
SUMMARY: Deloitte predicts that the percentage of virtual video visits to doctors will rise to 5% globally in 2021, up from an estimated 1% in 2019. billion doctor’s visits, worth a total of approximately US$500 billion. Pharma’s content needs to focus on helping patients rather than selling them.
Digital pharma marketers have to “sell” the organization on the promise of digital marketing, but they also need to communicate that along with successes, there could be many failures. To master digital marketing, pharma needs to be prepared to fail. I’m optimistic that pharma can make it happen.
Consistently we heard that they like images of real patients or a REAL doctor with one key message communicated. They understand that patient content could be edited to meet FDA requirements, but they like reading others’ experiences managing their health issues. 9ine: “Why aren’t pharma websites updated?”
Pharma HCP managers must also triage their messages to physicians. Docs don’t like pharma listening in their conversations to one another, and they really don’t like leaders intervening in their conversations if it’s too promotional. When using the Internet to reach doctors, numbers don’t matter.
Ever wonder why some pharma brands dominate the top of search results while others get buried? Imagine a doctors waiting room filled with brochures; only a few stand out. Standing out in pharma requires more than compliant messaging; it demands visibility. It’s not just luck or big budgetsits strategy.
For pharma sales reps, these programs are not just tools for market penetration – they’re lifelines that improve healthcare accessibility across the country. Similarly, oncology drug programs often provide free cycles of treatment to help patients manage costs while maintaining access to critical care. What Are Drug Access Programs?
Talented marketers don’t want a career in pharma because of the culture. Many pharma agencies have allowed and sometimes forced experienced, talented people to leave while replacing them with inexpensive unproven people, and it shows. 1ne: Pharma companies are forcing out older, experienced employees. Pure fantasy.
Nowhere is this clearer than in pharma DTC TV ads. patients, and caregivers, are very active on social media and often reach out to each other to compare treatments and OTC products to help manage their M.S. DTC managers are often surprised by the results. viewers still see linear T.V. advertising frequency as “excessive.”
Ask a diabetes patient which pharma company is the leader in diabetes therapy? There was a time when TV ads were the driving force for pharma, but that time has passed. 5ive: How can I “sell” digital to management? Selling digital to management is a constant. The post Is pharma digital ready?
In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. This intent-driven nature gives pharma companies a distinct advantagereaching consumers when theyre most receptive.
By 6:30 AM, youre reviewing your schedule over breakfast and checking your WhatsApp messages for updates from doctors, pharmacists, or managers. The Perk: Doctors at private hospitals are often more receptive to new ideas and innovations. You might meet a doctor, pharmacist, or even a fellow sales rep for a quick meal.
In the world of Malaysian pharma sales, Zainal wasn’t just a manager. While other bosses were stuck in boardrooms, Zainal was out with his reps, visiting pharmacies in Ipoh or meeting doctors in Kota Bharu. The Legacy of Boss Zainal Today, Zainal’s name is almost legendary in the local pharma scene. He was the boss.
Consumers would ask their doctor about an advertised prescription drug in a perfect world. Most patients said they had done more research online or talked to other patients about their experience before asking their doctor about the brand. In our REAL world, that isn’t the way it happens. The research was straightforward.
Yesterday 60 Minutes aired a segment from a former Facebook Product Manager who said that Facebook was aware of misinformation but chose to leave it in their algorithms because it led to more engagement. A year ago, Facebook was making a hard charge to get the pharma business. This includes health information as well.
From treating doctors and providers as partners to viewing your role as an extension to help others in that partnership, he shows how far one can go in the industry when you know how to communicate. Also, I was like, “I probably don’t want to be a doctor because they have to go to school for a long time.” I was an athlete.
.” 62% of physicians agree that the info pharma companies provide on third-party websites for healthcare professionals “are always ads” for their products, and only one in three (34%) trust the information pharmas provide on these websites. Pharma generally needs a small dose of empathy when talking/marketing to physicians.
Here are 10 little-known facts about working as a medical sales rep in a local generic pharma company—and what you can expect from this dynamic and rewarding role. Doctors, pharmacists, and procurement officers often scrutinize every ringgit, especially when government budgets are tight or private hospitals weigh profit margins.
Those DTC managers who use the exact roadmap will waste a lot of money when accountability is increasing. Pharma companies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. DTC marketing has evolved. Challenge #1 – DIGITAL MARKETING.
However, despite being one of the biggest markets in pharma, diabetes drugmakers have a hard time standing out in the crowded field, and many patients still aren’t confident in their ability to manage their disease. Reach Patients During Doctor Discussions at the Point of Care.
Imagine a time when pharmaceutical ads simply told patients what to ask their doctor. For pharma marketing executives and brand teams, understanding this evolution is essential to remaining competitive and compliant in a rapidly shifting healthcare environment. Pharma marketers must now meet them where they areonline and engaged.
At the heart of this transformation is the role of medical affairs, which is undergoing something of a rebrand as it moves from supporting function to strategic partner within the broader pharma organization. Pharma’s Data Dichotomy Without a doubt, pharma’s primary mission is to create and provide treatments for patients.
There is going to be more coverage for virtual doctors’ visits in new employee health plans along with expanded mental health benefits and access to on-site health clinics. The weight management services should be mandatory as obese employees are liable to cost companies and insurers more. What does this mean for DTC marketers?
Until the COVID-19 pandemic struck the world in early 2020, pharma had been pretty resistant to the idea of involving the end-customer, or the patient, into their business models. This increased recognition among every day people practically handed pharma the chance to reconsider its direct relationship with patients.
The Evolution of Pharma Sales: Combining AI and Social Media to Promote Brands Pharmaceutical businesses now have access to a whole new level of insights due to social media. According to a study by MedData Group, 38% of doctors use Instagram and LinkedIn on a weekly basis , and 72% of doctors use Facebook.
The old belief is that patients who are interested in new treatments ask their doctor about them. While pharma product websites stop the train for online health seekers, the vast majority fail to provide the information needed to convince people to ask for an advertised product. That belief is out the window. What are the side effects?
Pharma Selling: What Doctors expect from Medical Sales Reps? Sales representatives in the healthcare industry are expected to manage their “territories” as if they were running their own business. One major goal of a medical sales representative is to be seen as a valued consultant by Doctors. hospital managers.
SUMMARY: Both emergency room visits and doctors’ visits are down by about half because people are putting off treatment for medical emergencies due to fears of contracting COVID-19. How is pharma going to get patients back into to ask their doctor about branded medications?
With the assistance of AI tools, pharma marketers can develop personalized sales messages and educational content, improving their engagement with healthcare providers and equipping them to deliver better patient care. Gone are the days of vague marketing messages such as “Ask your doctor if this is right for you.”
Typically, results or new treatment prescriptions are simply uploaded to the portal with the doctors expected to give explanations during the appointment—even though the ability to provide additional information within the portal is readily available. However, only 32% of patients trust pharma-developed apps.
OPENING: Pharma companies are starting to embrace digital marketing forced, in large part, by changes brought on by the pandemic. Before COVID-19, 64% of meetings with pharma sales reps were held in person. And, in fact, 61% said they are interacting with pharma sales reps more during COVID-19 than they did before.
PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The new initiative, Care Studio, aims at doctors rather than patients. Will pharma and other healthcare companies partner with disruptive organizations?
For instance, 61% of ophthalmologists cite poor adherence with existing treatments as a challenge; services to help patients and caregivers manage their condition emerged as their top need during the treatment stage. Pharma reps are especially critical when it comes to product information, with 55% of all U.S. In contrast, half of U.S.
In medical device markets, doctors, nurses and sometimes business administrators are our “celebrity” KOLs. At large pharma and medical device companies, there are entire departments devoted to the management of Key Opinion Leaders. The next several blog posts will cover practical KOL management strategies and tactics.
Leave Behind Literatures (LBLs) serves as a powerful tool that allows pharmaceutical marketers to provide tangible resources for doctors to refer to. Simply one can design comprehensive booklets that explain the therapeutic area, mechanisms of action, dosage, and patient management.
Our healthcare system makes too much money for insurers, PBM’s and pharma companies to change. Today, just as many people trust retailers and digital companies to help manage their personal health as they do health care providers.18. Sarasohn-Kahn tackles in her book HealthConsuming: From Health Consumer to Health Citizen.
(New York Times ) If you spend any time reading pharma PR releases, you’ll see over and over again corporate managements stressing the importance of the shareholder. Can a pharma company serve both shareholders and patients? Today’s pharma CEOs are interested in one thing; did we hit the sale number?
With a lot of money pouring in from MS drugs, their CEO decided that they needed to act like big pharma and moved the company to downtown Cambridge under the guise that it was necessary to get closer to biomedical R&D. After the CEO departed the sinking ship, new management pinned all their hopes on the Biogen drug for Alzheimer’s.
Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses. Nobody buys pills.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content